These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Antiestrogenic and antitumor properties of tamoxifen in laboratory animals. Jordan VC. Cancer Treat Rep; 1976 Oct; 60(10):1409-19. PubMed ID: 828517 [Abstract] [Full Text] [Related]
3. Approaches to combination chemotherapy in rat, mouse, and hamster tumors. Griswold DP, Dykes DJ, Kelley CA, Roberts BJ, Dominick CA. Cancer Chemother Rep 2; 1974 Mar; 4(1):99-108. PubMed ID: 4524043 [No Abstract] [Full Text] [Related]
4. Cytostatic activity of an estradiol-linked nitrosourea in MXT mammary carcinoma and L 5222 leukemia. Zeller WJ, Schreiber J, Petru E, Eisenbrand G. Arzneimittelforschung; 1989 Dec; 39(12):1577-9. PubMed ID: 2624608 [Abstract] [Full Text] [Related]
5. Enhanced regression of DMBA-induced mammary cancers in rats by combination of ergocornine with ovariectomy or high doses of estrogen. Quadri SK, Kledzik GS, Meites J. Cancer Res; 1974 Mar; 34(3):499-501. PubMed ID: 4812257 [No Abstract] [Full Text] [Related]
11. Immunologic and chemotherapeutic parameters in a model breast tumor system. Rugmann RA, Stolfi RL, Hayworth PE, Martin DS. Cancer Chemother Rep 2; 1974 Mar; 4(1):25-32. PubMed ID: 4826497 [No Abstract] [Full Text] [Related]
12. Effect of medroxyprogesterone acetate and doxorubicin on sublines of 13762 mammary adenocarcinoma in rats. Formelli F, Zaccheo T, Casazza AM, Bellini O, Di Marco A. Eur J Cancer Clin Oncol; 1981 Nov; 17(11):1211-21. PubMed ID: 6460631 [No Abstract] [Full Text] [Related]
13. Effects of ergocornine and ergocryptine on growth of 7,12-dimethylbenzanthracene-induced mammary tumors in rats. Cassell EE, Meites J, Welsch CW. Cancer Res; 1971 Jul; 31(7):1051-3. PubMed ID: 5560385 [No Abstract] [Full Text] [Related]
14. Regression of spontaneous mammary tumors in rats by ergot drugs. Quadri SK, Meites J. Proc Soc Exp Biol Med; 1971 Dec; 138(3):999-1001. PubMed ID: 5131642 [No Abstract] [Full Text] [Related]
15. Prophylaxis of spontaneously developing mammary carcinoma in C3H-HeJ female mice by suppression of prolactin. Welsch CW, Gribler C. Cancer Res; 1973 Nov; 33(11):2939-46. PubMed ID: 4795906 [No Abstract] [Full Text] [Related]
16. Hypophysectomy and injections of high doses of estrogens inhibit the growth of ovary-independent rat mammary carcinomas. Nomura S, Yoshida H, Kaneko Y. In Vivo; 1990 Nov; 4(2):121-5. PubMed ID: 1966585 [Abstract] [Full Text] [Related]
17. Effect of ergocornine on transplanted mammary tumor growth and pituitary prolactin level in BALB/c mice. Singh DV, Meites J, Halmi L, Kortright KH, Brennan MJ. J Natl Cancer Inst; 1972 Jun; 48(6):1727-31. PubMed ID: 5056256 [No Abstract] [Full Text] [Related]
18. Inhibition of mammary tumorigenesis by ergot alkaloids and promotion of mammary tumorigenesis by pituitary isografts in adreno-ovariectomized mice. Yanai R, Nagasawa H. J Natl Cancer Inst; 1972 Mar; 48(3):715-9. PubMed ID: 5058970 [No Abstract] [Full Text] [Related]
19. Suppression of mammary hyperplastic nodule formation and pituitary prolactin secretion in mice induced by ergocornine or 2-bromo-a-ergocryptine. Yanai R, Nagasawa H. J Natl Cancer Inst; 1970 Dec; 45(6):1105-12. PubMed ID: 5530649 [No Abstract] [Full Text] [Related]
20. Direct inhibiting effects of [D-Trp6]gonadotropin-releasing hormone on the estrogen-sensitive progression of polyoma virus-induced mammary tumors in athymic mice. Néri C, Blangy D, Schatz B, Drieu K, Berebbi M, Martin PM. Cancer Res; 1990 Sep 15; 50(18):5892-7. PubMed ID: 2168284 [Abstract] [Full Text] [Related] Page: [Next] [New Search]